A Comparison of Polyherbal Tablets to Treat Type II Diabetes

Authors

  • Raghuveer R Research Scholar, Mother Theresa Post Graduate and Research Institute of Health Sciences, Gorimedu, Indra Nagar, Puducherry-605 006, Tamil Nadu, India
  • Gopal V Department of Pharmacognosy, Mother Theresa Post Graduate and Research Institute of Health Sciences, Gorimedu, Indra Nagar, Puducherry-605 006, Tamil Nadu, India

DOI:

https://doi.org/10.26452/fjphs.v1i2.230

Keywords:

Glycyrrhiza, Tribulus, Anti-diabetic tablets, Piper, Diabetes

Abstract

The most pervasive problems today include the burden of disease and its complexities. While diabetes is not an infectious disease, it is caused by a healthy diet and bad eating habits. The causes of diabetes are unhealthy dietary patterns, attributable to insufficient pancreas insulin secretion and insulin receptor insensitivity, caused by process wisdom. It results in improper glucose metabolism and reuptake into the muscles. Various synthetic drugs are used successfully to regulate diabetes. The drugs have those side effects, which make their use limited, because of the fear of creating such complications. Different diseases have been treated with herbs and medicinal plants in this respect, and are often considered to be effective and safer. Many herbs are now used to treat diabetes, and it has also been researched and shown the exact mode of action of all those herbs. Chemical leads have been isolated and shown to be effective against diabetes from plants. The tablet formulation can control the amount of blood sugar in the current study for diabetes caused by STZ. This was prepared using extracts from Withania somnifera, Psidium guava, Trigonella foenumgracum, and Piper nigrum and anti-diabetic property testing revealed that compared to standard and individual extracts, the tablets showed greater activity.

Downloads

Download data is not yet available.

Published

2021-03-15

How to Cite

Raghuveer R, & Gopal V. (2021). A Comparison of Polyherbal Tablets to Treat Type II Diabetes. Future Journal of Pharmaceuticals and Health Sciences, 1(2), 50–53. https://doi.org/10.26452/fjphs.v1i2.230

Issue

Section

Original Articles

Similar Articles

You may also start an advanced similarity search for this article.